UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates
December 02, 2020
December 02, 2020
LAS VEGAS, Nevada, Dec. 2 (TNSRes) -- The University of Nevada Las Vegas campus issued the following news release:
Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to "normal life."
Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectivene . . .
Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to "normal life."
Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectivene . . .